Buprenorphine Tablet
Product Images NDC 50268-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 50268-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (128 15)

50 (128 15)
This text contains information about Buprenorphine Sublingual Tablets, with National Drug Code 50268.128.15. It mentions a unit dose of 50 tablets and provides some safety instructions and precautions for use, especially in emergencies involving children.*
FDA Label Image

50 (129 15)

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.